Newsroom

SynBiotic SE attracts Canopy Growth founder Bruce Linton as Chairman of newly created Advisory Board

SynBiotic SE, (SBX.DE) one of Germany’s leading cannabinoid companies, accelerates implementation of the operational platform to achieve market leadership in the upcoming national legalization of recreational cannabis by

Date - Cryptocurrency X Webflow Template
November 24, 2022

Recent Articles Corporate News

More Corporate News
Date - Cryptocurrency X Webflow Template
October 31, 2022

SynBiotic SE successfully completes capital increase and places all new shares

Date - Cryptocurrency X Webflow Template
October 26, 2022

“Like winning the lottery” SynBiotic SE comments on key points paper (“Eckpunktepapier”)

Date - Cryptocurrency X Webflow Template
August 31, 2022

Hempamed Rx: SynBiotic SE launches full-line medical cannabis brand

Recent Press Reviews

More Press Reviews
Date - Cryptocurrency X Webflow Template
April 22, 2022

SynBiotic SE & Enchilada Group: Joint Venture To Launch First Cannabis Store In Germany

Date - Cryptocurrency X Webflow Template
January 15, 2022

CannaList Conversations with Lars Müller, CEO of SynBiotic SE

Date - Cryptocurrency X Webflow Template
December 6, 2021

Lars Mueller Explains How SynBiotic Uses The Power of Cannabinoids To Heal Modern World Diseases

Recent Ad Hoc Releases

More Ad Hoc Releases
Date - Cryptocurrency X Webflow Template

Adhoc: SynBiotic SE: Beabsichtigte Kapitalerhöhung gegen Bareinlagen mit Bezugsrecht.

Date - Cryptocurrency X Webflow Template
October 28, 2022

Adhoc: SynBiotic SE: Durchführung einer Kapitalerhöhung beschlossen

Date - Cryptocurrency X Webflow Template
September 21, 2022

SynBiotic SE: Änderung des Platzierungspreises aus der am 2. September 2022 beschlossenen Barkapitalerhöhung

HomeInvestor RelationsTeamAbout usNewsroom
Privacy PolicyImprint
SynBiotic SE
Barer Str. 7
80333 München
office@synbiotic.com
© All rights reserved.
Made by SynBiotic